{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T19:35:43Z","timestamp":1789414543201,"version":"build-2803163510"},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","award":["[VGH-105-C-051]"],"award-info":[{"award-number":["[VGH-105-C-051]"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.ijantimicag.2018.10.015","type":"journal-article","created":{"date-parts":[[2018,10,27]],"date-time":"2018-10-27T02:13:57Z","timestamp":1540606437000},"page":"185-189","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Clinical characteristics of Candida tropicalis fungaemia with reduced triazole susceptibility in Taiwan: a multicentre study"],"prefix":"10.1016","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8593-8492","authenticated-orcid":false,"given":"Wei-Lun","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Tsung","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Han","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ing-Moi","family":"Hii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Lin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao-Wang","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Eng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8667-4844","authenticated-orcid":false,"given":"Yen-Hsu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-Der","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 6","key":"10.1016\/j.ijantimicag.2018.10.015_bib0001","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/1469-0691.12539","article-title":"Global trends in the distribution of Candida species causing candidemia","volume":"20","author":"Guinea","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2018.10.015_bib0002","doi-asserted-by":"crossref","first-page":"e99103","DOI":"10.1371\/journal.pone.0099103","article-title":"Epidemiology and prognostic factors of candidemia in cancer patients","volume":"9","author":"Tang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2018.10.015_bib0003","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ijantimicag.2013.09.005","article-title":"Nosocomial bloodstream infections due to Candida spp. in the USA: species distribution, clinical features and antifungal susceptibilities","volume":"43","author":"Wisplinghoff","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2018.10.015_bib0004","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1128\/AAC.01035-13","article-title":"Antifungal susceptibilities of Candida isolates causing bloodstream infections at a medical center in Taiwan, 2009\u20132010","volume":"58","author":"Huang","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.10.015_bib0005","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1574-6976.2011.00278.x","article-title":"Candida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance","volume":"36","author":"Silva","year":"2012","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2018.10.015_bib0006","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127534","article-title":"Clinical and therapeutic aspects of candidemia: a five year single centre study","volume":"10","author":"Bassetti","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2018.10.015_bib0007","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.cmi.2015.06.010","article-title":"Incidence and species distribution of candidaemia in Asia: a laboratory-based surveillance study","volume":"21","author":"Tan","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2018.10.015_bib0008","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1128\/JCM.03044-13","article-title":"Impact of new antifungal breakpoints on antifungal resistance in Candida species","volume":"52","author":"Fothergill","year":"2014","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2018.10.015_bib0009","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ1194","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2018.10.015_bib0010","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antifungal susceptibility testing of yeasts, 1st edition. CLSI supplement M60. Wayne, PA: CLSI, 2017."},{"key":"10.1016\/j.ijantimicag.2018.10.015_bib0011","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1128\/JCM.01230-13","article-title":"Epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole for six Candida species as determined by the colorimetric Sensititre YeastOne method","volume":"51","author":"Cant\u00f3n","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2018.10.015_bib0012","doi-asserted-by":"crossref","first-page":"3944","DOI":"10.1128\/AAC.00285-15","article-title":"Antifungal susceptibility profiles of bloodstream yeast isolates by Sensititre YeastOne over nine years at a large Italian teaching hospital","volume":"59","author":"Posteraro","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.10.015_bib0013","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1093\/jac\/dkv087","article-title":"The ever-evolving landscape of candidaemia in patients with acute leukaemia: non-susceptibility to caspofungin and multidrug resistance are associated with increased mortality","volume":"70","author":"Wang","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2018.10.015_bib0014","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1093\/cid\/cis021","article-title":"Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials","volume":"54","author":"Andes","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2018.10.015_bib0015","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jinf.2015.05.009","article-title":"Candida tropicalis bloodstream infection: incidence, risk factors and outcome in a population-based surveillance","volume":"71","author":"Fernandez-Ruiz","year":"2015","journal-title":"J Infect"},{"key":"10.1016\/j.ijantimicag.2018.10.015_bib0016","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1097\/CCM.0000000000000221","article-title":"Impact of therapeutic strategies on the prognosis of candidemia in the ICU","volume":"42","author":"Puig-Asensio","year":"2014","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2018.10.015_bib0017","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.diagmicrobio.2016.02.009","article-title":"Antifungal susceptibility patterns of a global collection of fungal isolates: results of the SENTRY antifungal surveillance program (2013)","volume":"85","author":"Castanheira","year":"2016","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2018.10.015_bib0018","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.diagmicrobio.2016.09.009","article-title":"The distribution and drug susceptibilities of clinical Candida species in TSARY 2014","volume":"86","author":"Zhou","year":"2016","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2018.10.015_bib0019","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3109\/13693780903154070","article-title":"The distribution of species and susceptibility of amphotericin B and fluconazole of yeast pathogens isolated from sterile sites in Taiwan","volume":"48","author":"Yang","year":"2010","journal-title":"Med Mycol"},{"key":"10.1016\/j.ijantimicag.2018.10.015_bib0020","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1089\/mdr.2009.0915","article-title":"Two closely related fluconazole-resistant Candida tropicalis clones circulating in Taiwan from 1999 to 2006","volume":"15","author":"Li","year":"2009","journal-title":"Microb Drug Resist"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857918303078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857918303078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T12:57:00Z","timestamp":1565269020000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857918303078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S0924857918303078"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2018.10.015","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical characteristics of Candida tropicalis fungaemia with reduced triazole susceptibility in Taiwan: a multicentre study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2018.10.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}